In vivo and in vitro estrogenic and progestagenic actions of Tibolone
Estrogen and progestin combination in hormone replacement therapy (HRT) increases the incidence of breast cancer, but decreases the endometrial cancer risk of unopposed estrogen. Therefore, a SERM such as Tibolone, that delivers the beneficial, but not the adverse side effects, of steroid hormones w...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Language: | English |
| Published: |
Sociedad de Biología de Chile
2005
|
| Subjects: | |
| Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602005000200014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|